Abstract

This study is to compare the survival outcomes of laparoscopic radical hysterectomy (LRH) to those of abdominal radical hysterectomy (ARH) for patients with locally advanced cervical cancer (LACC). Patients with the International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IB2 to IIB LACC who underwent radical hysterectomy between 2001 and 2015 were identified. The disease-free survival (DFS) and overall survival (OS) were compared according to the surgical approach and were adjusted based on clinicopathologic characteristics. A total of 396 patients were included in the study, with 179 (45.2%) and 217 (54.8%) patients in the ARH and LRH groups, respectively. The LRH group showed a significantly lower amount of estimated blood loss, lower blood transfusion rate and shorter length of hospital stay. Overall, there were no significant differences in the 5-year DFS and 5-year OS between the LRH and ARH groups with the Kaplan-Meier method. However, multivariate analyses identified LRH as an independent prognostic factor for a poor DFS (hazard ratio [HR] 2.5; 95% confidence interval [95% CI] 0.19 to 0.87; p = 0.02). The analysis of stage IB2 disease and the squamous subtype (61.9% and 87.9% of all participants, respectively) reached the same conclusion. When stratifying by FIGO stage, the patients with IB2 (n = 348) in the ARH group had a significantly better DFS (HR 0.14, 95% CI 0.05–0.42, p < 0.01) and OS (HR 0.17, 95% CI 0.04–0.67, p = 0.11) than those in the LRH group in the Cox regression model. However, no differences were found in patient with stage IIA1, IIA2, or IIB in Cox regression model. When stratifying by histological types, for the patients with squamous carcinomas (n = 375), in Cox model, ARH had a significantly superior DFS compared with those who underwent LRH (HR 0.45, 95% CI 0.25–0.82, p = 0.01), but the OS was not statistically significant (HR 0.57, 95% CI 0.27–1.20, p = 0.14). However, no differences were found in patient with adenocarcinoma and adenosquamous carcinomas in the Cox model. Therefore, ARH was associated with a higher DFS than LRH in patients with LACC, especially in patients with stage IB2 disease or the squamous subtype.

Highlights

  • Cervical cancer (CC) is one of most common cancer-related deaths among women worldwide [1]

  • We reported a large cohort of locally advanced cervical cancer (LACC) patients who underwent radical hysterectomy (RH) with or without neoadjuvant chemotherapy (NAC)

  • The surgical and survival outcomes between abdominal radical hysterectomy (ARH) and laparoscopic radical hysterectomy (LRH) could become the basis of decision making for physicians and patients, which could probably improve the quality of life of these relatively young patients

Read more

Summary

Introduction

Cervical cancer (CC) is one of most common cancer-related deaths among women worldwide [1]. Advanced cervical cancer (LACC) refers to stage IB2, IIA, and IIB carcinomas, classified by the International Federation of Gynecology and Obstetrics (FIGO) staging system [3]. The treatment for women with LACC remains challenging. The standard treatment for LACC is cisplatin-based concurrent chemoradiotherapy (CCRT) [4, 5]. Surgical treatment, including radical hysterectomy (RH) followed by adjuvant treatment is a preferred treatment option for LACC in some circumstances [6, 7] and could offer potential benefits, including reducing the burden of tumor, preserving ovarian function and precisely determining the postoperative stage on the basis of histopathologic findings, thereby allowing quality of life improvements in young patients and individualizing postoperative treatment [4]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call